In human cancers, decreased p57KIP2 expression is observed in various types of malignancies, including hepatocellular [151], prostate [165], colorectal [166], pancreatic [167], pulmonary [168], and breast [169], as well as in bladder cancer [170]. The gene discussed is CDKN1C; the disease is cancer.